Premium
P4‐212: DRUG DEVELOPMENT OF INHIBITORS OF TAU OLIGOMER FORMATION FOR ALZHEIMER'S DISEASE AND TAUOPATHIES
Author(s) -
Moe James G.,
Krishnamurthy Pavan,
Lopez Patricia,
Papiani Giulia,
Hendrix James,
Davidowitz Eliot Jonathan
Publication year - 2014
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2014.05.1730
Subject(s) - tauopathy , oligomer , drug discovery , tau pathology , drug development , in vivo , drug , neuroscience , hippocampal formation , chemistry , small molecule , lead compound , disease , pharmacology , alzheimer's disease , in vitro , biochemistry , biology , medicine , neurodegeneration , pathology , genetics , organic chemistry